MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12882-016-0270-2

Медицинская библиотека · BMC nephrology · 2016

Impaired P2Y12 inhibition by clopidogrel in kidney transplant recipients: results from a cohort study.

Muller Clotilde, Messas Nathan, Perrin Peggy, Olagne Jerome, Gautier-Vargas Gabriela, Cognard Noelle, Caillard Sophie, Moulin Bruno, Morel Olivier

СтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Cardiovascular complications represent a major cause of morbidity and mortality for patients who received kidney transplantation (KT). However, the impact of KT and chronic immunosuppression on platelet response to clopidogrel in patients undergoing coronary or peripheral revascularization procedures remains unclear. This cohort study compares platelet responsiveness to clopidogrel as assessed byvasodilator-stimulated phosphoprotein (VASP) phosphorylation.

METHODS

The study population was divided between chronic kidney disease (CKD) patients who underwent KT (n = 36) and non-transplanted CKD patients (control group, n = 126). Patients were on maintenance antiplatelet therapy with clopidogrel 75 mg daily for at least 8 days. The mean platelet reactivity index (PRI) VASP values and the prevalence of high on-treatment platelet reactivity (HPR, defined as PRI VASP ≥61 %) were compared.

RESULTS

The mean PRI VASP value was significantly higher in the transplant group (60.1 ± 3 vs 51.2 ± 1.6 %; p=0.014). HPR was significantly more common in the transplant group on clopidogrel maintenance therapy (58 vs. 31 %; p = 0.011). KT was the only independent predictor of HPR (odds ratio: 2.6; 95 % confidence interval: 1.03-6.27, p = 0.03). The effect of treatment with calcineurin inhibitors on clopidogrel response could not be analyzed separately from the kidney transplant status.

CONCLUSIONS

KT is associated with an increased prevalence of HPR. Our results suggest that plateletfunction tests may be clinically useful for the management of this specific population.

Для цитирования: Muller Clotilde, Messas Nathan, Perrin Peggy, Olagne Jerome, Gautier-Vargas Gabriela, Cognard Noelle, Caillard Sophie, Moulin Bruno, Morel Olivier. Impaired P2Y12 inhibition by clopidogrel in kidney transplant recipients: results from a cohort study.. BMC nephrology. 2016. DOI: 10.1186/s12882-016-0270-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.